Events & Presentations

Upcoming Events
Date Event Details Remind Me
Feb 6, 2023 4:30 PM EST
Arrowhead Pharmaceuticals 2023 First Quarter Results
Archived Events
Date Event Details
Jan 9, 2023 11:15 AM EST
41st Annual J.P. Morgan Healthcare Conference
Jan 9, 2023 8:30 AM EST
Fazirsiran Phase 2 SEQUOIA Study Webcast
Dec 1, 2022 11:20 AM EST
Evercore ISI 5th Annual HealthCONx Conference
Presenter: Christopher Anzalone, Ph.D., President and CEO
Nov 30, 2022 2:00 PM EST
Piper Sandler 34th Annual Healthcare Conference
Presenter: Christopher Anzalone, Ph.D., President and CEO
Nov 28, 2022 4:30 PM EST
Arrowhead Pharmaceuticals Fiscal 2022 Year End Results
Nov 9, 2022 10:00 AM EST
Virtual ARO-APOC3 and ARO-ANG3 Investor Event
Nov 5 - Nov 7, 2022
American Heart Association (AHA) Scientific Sessions 2022

Title: ARO-ANG3, an Investigational RNAi Therapeutic, Decreases Serum Angiopoietin-Like Protein 3, Triglycerides, and Cholesterol in Patients With Mixed Dyslipidemia
Date/Time: November 7, 2022, 3:00 p.m. CST
Presenter: Robert S. Rosenson
Session: The Present and Future of Lipid Lowering
 

Title: ARO-APOC3, an Investigational RNAi Therapeutic, Decreases Serum Apolipoprotein C3, Triglyceride, and Non-HDL-C Concentrations While Increasing HDL-C in Patients With Severe Hypertriglyceridemia
Date/Time: November 7, 2022, 3:08 p.m. CST
Presenter: Christie M. Ballantyne
Session: The Present and Future of Lipid Lowering
 

Oct 4, 2022 2:00 PM EDT
Chardan’s 6th Annual Genetic Medicines Summit
Type: Fireside chat presentation
Presenter: Vincent Anzalone, Vice President Finance and Investor Relations, Arrowhead Pharmaceuticals
Sep 14, 2022 3:30 PM EDT
Morgan Stanley 20th Annual Global Healthcare Conference

Note: Presentation Cancelled

Type: Fireside chat presentation
Presenter: Christopher Anzalone, Ph.D., President and CEO, Arrowhead Pharmaceuticals

Sep 13, 2022 4:20 PM EDT
Baird 2022 Global Healthcare Conference
Type: Fireside chat presentation
Presenter: Christopher Anzalone, Ph.D., President and CEO, Arrowhead Pharmaceuticals